Byler Disease Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 90 pages | ID: B8A593A1F43AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Byler Disease Treatment in Global, including the following market information:

Global Byler Disease Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Byler Disease Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Byler Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Byler Disease Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Byler Disease Treatment Market Segment Percentages, By Type, 2020 (%)

• Medical Treatment
• Surgical Treatment

China Byler Disease Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Byler Disease Treatment Market Segment Percentages, By Application, 2020 (%)

• Research Centers
• Hospitals
• Clinics
• Others

Global Byler Disease Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Byler Disease Treatment Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Byler Disease Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Byler Disease Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Merck
• Sanofi AG
• Novartis AG
• Bayer AG
• GlaxoSmithKline plc
• AstraZeneca PLC
• Pfizer Inc
• Bristol-Myers Squibb Company
• Gilead Science Inc.
• Johnson & Johnson Private Limited

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Inhalational Anaesthesia Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Inhalational Anaesthesia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INHALATIONAL ANAESTHESIA DRUGS OVERALL MARKET SIZE

2.1 Global Inhalational Anaesthesia Drugs Market Size: 2021 VS 2027
2.2 Global Inhalational Anaesthesia Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Inhalational Anaesthesia Drugs Players in Global Market
3.2 Top Global Inhalational Anaesthesia Drugs Companies Ranked by Revenue
3.3 Global Inhalational Anaesthesia Drugs Revenue by Companies
3.4 Top 3 and Top 5 Inhalational Anaesthesia Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Inhalational Anaesthesia Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Inhalational Anaesthesia Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Inhalational Anaesthesia Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Inhalational Anaesthesia Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Inhalational Anaesthesia Drugs Market Size Markets, 2021 & 2027
  4.1.2 Enflurane
  4.1.3 Isoflurane
  4.1.4 Halothane
  4.1.5 Sevoflurane
  4.1.6 Atropine
4.2 By Type - Global Inhalational Anaesthesia Drugs Revenue & Forecasts
  4.2.1 By Type - Global Inhalational Anaesthesia Drugs Revenue, 2016-2021
  4.2.2 By Type - Global Inhalational Anaesthesia Drugs Revenue, 2022-2027
  4.2.3 By Type - Global Inhalational Anaesthesia Drugs Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Inhalational Anaesthesia Drugs Market Size, 2021 & 2027
  5.1.2 Hospital Pharmacies
  5.1.3 Online Pharmacies
  5.1.4 Retail Pharmacies
5.2 By Application - Global Inhalational Anaesthesia Drugs Revenue & Forecasts
  5.2.1 By Application - Global Inhalational Anaesthesia Drugs Revenue, 2016-2021
  5.2.2 By Application - Global Inhalational Anaesthesia Drugs Revenue, 2022-2027
  5.2.3 By Application - Global Inhalational Anaesthesia Drugs Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Inhalational Anaesthesia Drugs Market Size, 2021 & 2027
6.2 By Region - Global Inhalational Anaesthesia Drugs Revenue & Forecasts
  6.2.1 By Region - Global Inhalational Anaesthesia Drugs Revenue, 2016-2021
  6.2.2 By Region - Global Inhalational Anaesthesia Drugs Revenue, 2022-2027
  6.2.3 By Region - Global Inhalational Anaesthesia Drugs Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Inhalational Anaesthesia Drugs Revenue, 2016-2027
  6.3.2 US Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.3.3 Canada Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.3.4 Mexico Inhalational Anaesthesia Drugs Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Inhalational Anaesthesia Drugs Revenue, 2016-2027
  6.4.2 Germany Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.4.3 France Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.4.4 U.K. Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.4.5 Italy Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.4.6 Russia Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.4.7 Nordic Countries Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.4.8 Benelux Inhalational Anaesthesia Drugs Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Inhalational Anaesthesia Drugs Revenue, 2016-2027
  6.5.2 China Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.5.3 Japan Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.5.4 South Korea Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.5.5 Southeast Asia Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.5.6 India Inhalational Anaesthesia Drugs Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Inhalational Anaesthesia Drugs Revenue, 2016-2027
  6.6.2 Brazil Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.6.3 Argentina Inhalational Anaesthesia Drugs Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Inhalational Anaesthesia Drugs Revenue, 2016-2027
  6.7.2 Turkey Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.7.3 Israel Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.7.4 Saudi Arabia Inhalational Anaesthesia Drugs Market Size, 2016-2027
  6.7.5 UAE Inhalational Anaesthesia Drugs Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 AbbVie Inc.
  7.1.1 AbbVie Inc. Corporate Summary
  7.1.2 AbbVie Inc. Business Overview
  7.1.3 AbbVie Inc. Inhalational Anaesthesia Drugs Major Product Offerings
  7.1.4 AbbVie Inc. Inhalational Anaesthesia Drugs Revenue in Global (2016-2021)
  7.1.5 AbbVie Inc. Key News
7.2 Baxter
  7.2.1 Baxter Corporate Summary
  7.2.2 Baxter Business Overview
  7.2.3 Baxter Inhalational Anaesthesia Drugs Major Product Offerings
  7.2.4 Baxter Inhalational Anaesthesia Drugs Revenue in Global (2016-2021)
  7.2.5 Baxter Key News
7.3 Hikma Pharmaceuticals PLC
  7.3.1 Hikma Pharmaceuticals PLC Corporate Summary
  7.3.2 Hikma Pharmaceuticals PLC Business Overview
  7.3.3 Hikma Pharmaceuticals PLC Inhalational Anaesthesia Drugs Major Product Offerings
  7.3.4 Hikma Pharmaceuticals PLC Inhalational Anaesthesia Drugs Revenue in Global (2016-2021)
  7.3.5 Hikma Pharmaceuticals PLC Key News
7.4 Halocarbon Products Corporation
  7.4.1 Halocarbon Products Corporation Corporate Summary
  7.4.2 Halocarbon Products Corporation Business Overview
  7.4.3 Halocarbon Products Corporation Inhalational Anaesthesia Drugs Major Product Offerings
  7.4.4 Halocarbon Products Corporation Inhalational Anaesthesia Drugs Revenue in Global (2016-2021)
  7.4.5 Halocarbon Products Corporation Key News
7.5 Piramal Enterprises Limited
  7.5.1 Piramal Enterprises Limited Corporate Summary
  7.5.2 Piramal Enterprises Limited Business Overview
  7.5.3 Piramal Enterprises Limited Inhalational Anaesthesia Drugs Major Product Offerings
  7.5.4 Piramal Enterprises Limited Inhalational Anaesthesia Drugs Revenue in Global (2016-2021)
  7.5.5 Piramal Enterprises Limited Key News
7.6 Lunan Pharmaceutical Group Co. Ltd.
  7.6.1 Lunan Pharmaceutical Group Co. Ltd. Corporate Summary
  7.6.2 Lunan Pharmaceutical Group Co. Ltd. Business Overview
  7.6.3 Lunan Pharmaceutical Group Co. Ltd. Inhalational Anaesthesia Drugs Major Product Offerings
  7.6.4 Lunan Pharmaceutical Group Co. Ltd. Inhalational Anaesthesia Drugs Revenue in Global (2016-2021)
  7.6.5 Lunan Pharmaceutical Group Co. Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Byler Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Byler Disease Treatment Market Drivers in Global Market
Table 3. Byler Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Byler Disease Treatment in Global Market
Table 5. Top Byler Disease Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Byler Disease Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Byler Disease Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Byler Disease Treatment Product Type
Table 9. List of Global Tier 1 Byler Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Byler Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Byler Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Byler Disease Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Byler Disease Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Byler Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Byler Disease Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Byler Disease Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Byler Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Byler Disease Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Byler Disease Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Byler Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Byler Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Byler Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Byler Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Byler Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Byler Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Byler Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Byler Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Byler Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Byler Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Merck Corporate Summary
Table 31. Merck Byler Disease Treatment Product Offerings
Table 32. Merck Byler Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Sanofi AG Corporate Summary
Table 34. Sanofi AG Byler Disease Treatment Product Offerings
Table 35. Sanofi AG Byler Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Novartis AG Corporate Summary
Table 37. Novartis AG Byler Disease Treatment Product Offerings
Table 38. Novartis AG Byler Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Bayer AG Corporate Summary
Table 40. Bayer AG Byler Disease Treatment Product Offerings
Table 41. Bayer AG Byler Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 42. GlaxoSmithKline plc Corporate Summary
Table 43. GlaxoSmithKline plc Byler Disease Treatment Product Offerings
Table 44. GlaxoSmithKline plc Byler Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 45. AstraZeneca PLC Corporate Summary
Table 46. AstraZeneca PLC Byler Disease Treatment Product Offerings
Table 47. AstraZeneca PLC Byler Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Pfizer Inc Corporate Summary
Table 49. Pfizer Inc Byler Disease Treatment Product Offerings
Table 50. Pfizer Inc Byler Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Bristol-Myers Squibb Company Corporate Summary
Table 52. Bristol-Myers Squibb Company Byler Disease Treatment Product Offerings
Table 53. Bristol-Myers Squibb Company Byler Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Gilead Science Inc. Corporate Summary
Table 55. Gilead Science Inc. Byler Disease Treatment Product Offerings
Table 56. Gilead Science Inc. Byler Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 57. Johnson & Johnson Private Limited Corporate Summary
Table 58. Johnson & Johnson Private Limited Byler Disease Treatment Product Offerings
Table 59. Johnson & Johnson Private Limited Byler Disease Treatment Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Byler Disease Treatment Segment by Type
Figure 2. Byler Disease Treatment Segment by Application
Figure 3. Global Byler Disease Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Byler Disease Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Byler Disease Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Byler Disease Treatment Revenue in 2020
Figure 8. By Type - Global Byler Disease Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Byler Disease Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Byler Disease Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Byler Disease Treatment Revenue Market Share, 2016-2027
Figure 12. US Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Byler Disease Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Byler Disease Treatment Revenue Market Share, 2016-2027
Figure 24. China Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Byler Disease Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Byler Disease Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Byler Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Merck Byler Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Sanofi AG Byler Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Novartis AG Byler Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bayer AG Byler Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. GlaxoSmithKline plc Byler Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. AstraZeneca PLC Byler Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Pfizer Inc Byler Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Bristol-Myers Squibb Company Byler Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Gilead Science Inc. Byler Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)